Teriparatide
Bone-building hormone fragment
Healing & Recoverysubcutaneousany
Overview
Recombinant PTH (1-34) that stimulates bone formation. FDA-approved for osteoporosis. Anabolic effect on bone unlike bisphosphonates.
Dosing
- Typical Dosage
- 20 mcg
- Frequency
- Daily
- Cycle Duration
- Up to 2 years
- Administration
- subcutaneous
Available Vial Sizes
10mg
FDA-approved (Forteo). Maximum 2-year treatment course.
Comprehensive Information
AI-GeneratedGenerating comprehensive analysis...
This may take a moment
Mechanism of Action
Key Benefits
Optimal Timing
Potential Side Effects
Stacking Suggestions
Practical Tips
Could not load AI-generated information
Track Your Teriparatide Protocol
Join UpgradeYourself to track your peptide protocols, log injections with our interactive body map, and receive AI-powered insights tailored to your health goals.
Free forever planNo credit card required100+ peptides tracked